LIU, QIMIN
 Distribuzione geografica
Continente #
EU - Europa 112
NA - Nord America 112
AS - Asia 89
SA - Sud America 19
AF - Africa 2
Totale 334
Nazione #
US - Stati Uniti d'America 109
CN - Cina 38
RU - Federazione Russa 25
IT - Italia 24
IE - Irlanda 19
SG - Singapore 17
BR - Brasile 13
FI - Finlandia 12
DE - Germania 11
VN - Vietnam 11
GB - Regno Unito 6
HK - Hong Kong 6
JP - Giappone 5
BE - Belgio 3
IN - India 3
SE - Svezia 3
AM - Armenia 2
CA - Canada 2
LT - Lituania 2
NL - Olanda 2
PE - Perù 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
BY - Bielorussia 1
ES - Italia 1
GY - Guiana 1
HN - Honduras 1
ID - Indonesia 1
IL - Israele 1
KE - Kenya 1
LB - Libano 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
PH - Filippine 1
PY - Paraguay 1
UA - Ucraina 1
UY - Uruguay 1
Totale 334
Città #
Ashburn 17
Dublin 15
Boardman 11
Singapore 11
Helsinki 10
Chandler 7
Munich 7
New York 7
Beijing 6
Hong Kong 6
Dallas 5
Ho Chi Minh City 5
Los Angeles 5
Moscow 5
Tokyo 5
Wilmington 5
Changsha 4
Hebei 4
Nanjing 4
Seattle 4
St Petersburg 4
Turin 4
Brussels 3
Hanoi 3
Menlo Park 3
San Genesio Ed Uniti 3
Voronezh 3
Ann Arbor 2
Buffalo 2
Düsseldorf 2
Jacksonville 2
Lawrence 2
London 2
Medford 2
Nanchang 2
Piscataway 2
Princeton 2
Pune 2
Shanghai 2
Southend 2
São Paulo 2
Tianjin 2
Turku 2
Yerevan 2
Amsterdam 1
Ananindeua 1
Angeles City 1
Atlanta 1
Austin 1
Belém 1
Bengkalis 1
Boretto 1
Brest 1
Brotas 1
Bình An 1
Capão do Cipó 1
Casablanca 1
Charlotte 1
Chisinau 1
Ciudad del Este 1
College Park 1
El Progreso 1
Frankfurt am Main 1
Gatchina 1
Georgetown 1
Guangzhou 1
Haiphong 1
Hangzhou 1
Ilo 1
Itajaí 1
Jaru 1
Kuala Lumpur 1
Kunming 1
Kyiv 1
Lima region 1
Linköping 1
Manassas 1
Milan 1
Montevideo 1
Montreal 1
Navegantes 1
Ninh Bình 1
Nizhniy Novgorod 1
Nova Friburgo 1
Nuremberg 1
Orem 1
Passo Fundo 1
Pavia 1
Perm 1
Porto Alegre 1
Posadas 1
Redondo Beach 1
Redwood City 1
Richmond 1
Santa Clara 1
Shenzhen 1
Surat 1
São Luís 1
Tel Aviv 1
Vienna 1
Totale 256
Nome #
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease 132
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 117
Measurement of central exclusive pi(+)pi(-) production in p(p)over-bar collisions at root s=0.9 and 1.96 TeV at CDF 90
Totale 339
Categoria #
all - tutte 1.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.474


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 1 0 1 0 0 0 0
2021/202224 0 0 0 0 0 10 0 0 2 3 2 7
2022/202347 2 3 2 1 1 3 0 0 15 0 16 4
2023/202443 5 3 1 3 1 12 2 0 1 5 5 5
2024/202564 3 3 1 4 4 8 1 3 12 4 7 14
2025/2026117 14 16 25 26 23 13 0 0 0 0 0 0
Totale 339